280 related articles for article (PubMed ID: 29235674)
1. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Oral Squamous Cell Carcinoma Proliferation Through Crosstalk Between SMAD7 and CYLD.
Ge WL; Xu JF; Hu J
Cell Physiol Biochem; 2016; 38(3):1209-17. PubMed ID: 26982322
[TBL] [Abstract][Full Text] [Related]
3. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
4. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte elevated gene-1 promotes tumour growth and invasion by inducing EMT in oral squamous cell carcinoma.
Wang Y; Wang T; Sun Y; Sun W; Wang X
Sci Rep; 2017 Nov; 7(1):15447. PubMed ID: 29133850
[TBL] [Abstract][Full Text] [Related]
7. p130Cas induces bone invasion by oral squamous cell carcinoma by regulating tumor epithelial-mesenchymal transition and cell proliferation.
Yaginuma T; Gao J; Nagata K; Muroya R; Fei H; Nagano H; Chishaki S; Matsubara T; Kokabu S; Matsuo K; Kiyoshima T; Yoshioka I; Jimi E
Carcinogenesis; 2020 Aug; 41(8):1038-1048. PubMed ID: 31996896
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-218-5p promotes invasion of oral squamous cell carcinoma cells via activation of CD44-ROCK signaling.
Li X; He J; Shao M; Cui B; Peng F; Li J; Ran Y; Jin D; Kong J; Chang J; Duan L; Yang X; Luo Y; Lu Y; Lin B; Liu T
Biomed Pharmacother; 2018 Oct; 106():646-654. PubMed ID: 29990854
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
[TBL] [Abstract][Full Text] [Related]
10. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
11. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis.
Ibi H; Takahashi K; Harada H; Watabe T; Podyma-Inoue KA
Biochem Biophys Res Commun; 2024 Jun; 714():149965. PubMed ID: 38657447
[TBL] [Abstract][Full Text] [Related]
13. Membrane-tethered Notch1 exhibits oncogenic property via activation of EGFR-PI3K-AKT pathway in oral squamous cell carcinoma.
Zheng Y; Wang Z; Xiong X; Zhong Y; Zhang W; Dong Y; Li J; Zhu Z; Zhang W; Wu H; Gu W; Wu Y; Wang X; Song X
J Cell Physiol; 2019 May; 234(5):5940-5952. PubMed ID: 30515785
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells.
Sun H; Feng X
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378714
[TBL] [Abstract][Full Text] [Related]
15. SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.
Jiang W; Xu S; Li P
PLoS One; 2024; 19(4):e0301724. PubMed ID: 38625978
[TBL] [Abstract][Full Text] [Related]
16. CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma.
Pai S; Bamodu OA; Lin YK; Lin CS; Chu PY; Chien MH; Wang LS; Hsiao M; Yeh CT; Tsai JT
Cells; 2019 Dec; 8(12):. PubMed ID: 31861233
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
[TBL] [Abstract][Full Text] [Related]
18. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis.
Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC
Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420
[TBL] [Abstract][Full Text] [Related]
19. Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma.
Meng L; Zhao Y; Bu W; Li X; Liu X; Zhou D; Chen Y; Zheng S; Lin Q; Liu Q; Sun H
Cell Prolif; 2020 Aug; 53(8):e12859. PubMed ID: 32588946
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial activity and increase oxidative stress in oral carcinoma.
Kao YY; Chou CH; Yeh LY; Chen YF; Chang KW; Liu CJ; Fan Chiang CY; Lin SC
Cancer Lett; 2019 Aug; 456():40-48. PubMed ID: 31055111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
